Could NeuroEPO Become a New Alzheimer’s Treatment?

Yes, NeuroEPO could become a meaningful new treatment option for Alzheimer's disease, though it remains in the testing phase in most countries.

Yes, NeuroEPO could become a meaningful new treatment option for Alzheimer's disease, though it remains in the testing phase in most countries.

Midlife brain health matters more than people think because the biological changes that set the stage for cognitive decline—or cognitive resilience—begin...

Yes—personalized brain models are already beginning to guide Alzheimer's treatment, and evidence from recent clinical trials suggests they could...

Yes, immune-targeted treatments show genuine promise in slowing Alzheimer's disease progression, though the reality is more nuanced than the headlines...

Yes, studying memory formation is increasingly helping to treat dementia. Recent breakthroughs in understanding how the brain encodes and stores memories...

Memory protein research is revealing that the brain's ability to remember isn't an accidental side effect of neural activity—it's a deliberately...

Families need to know that alcohol affects the brain in profound and measurable ways—at all levels of consumption.

Yes, an experimental drug called CAQK, a four-amino acid peptide, shows remarkable promise in protecting brain tissue against multiple types of injury.

Yes, caregivers absolutely should ask doctors before adding any supplements to a person with dementia's routine.

Brain health marketing can mislead families because it uses unproven claims, scientific-sounding language, and deliberately targets older adults and their...